You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dry powder inhaler

Showing 1 - 25 of 4,322
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial (mometasone furoate dry powder inhaler, fluticasone propionate hydrofluoroalkane (HFA), montelukast)

Completed
Has Results
  • Asthma
  • mometasone furoate dry powder inhaler
  • +2 more
  • (no location specified)
Feb 7, 2022

Asthma Trial in Mineola (In-Check Dial, Inhaler Device)

Completed
  • Asthma
  • In-Check Dial
  • Inhaler Device
  • Mineola, New York
    Winthrop University Hospital
Feb 27, 2023

Health-related Quality of Life After Switching COPD Patients

Recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Spiriva® Respimat®
  • +2 more
  • Liestal, Switzerland
    Cantonal Hosp. Baselland,Univ.Med.Dept,Liestal
Jan 9, 2023

Pulmonary Disease, Chronic Obstructive Trial in Union (Part A: RPL554, Part B: RPL554, Placebos)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Part A: RPL554
  • +2 more
  • Union, South Carolina
    VitaLink Research -- Union
Aug 29, 2022

Asthma Trial in United States (Albuterol dry powder inhaler, Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler))

Completed
  • Asthma
  • Albuterol dry powder inhaler
  • Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)
  • Los Angeles, California
  • +8 more
Jan 18, 2022

Pulmonary Arterial Hypertension Trial in Kansas City (Placebo, Seralutinib, Generic Dry Powder Inhaler)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Placebo
  • +2 more
  • Kansas City, Kansas
    University of Kansas Medical Center
Jun 28, 2023

Asthma Trial (Mometasone furoate dry powder inhaler, Placebo)

Completed
Has Results
  • Asthma
  • Mometasone furoate dry powder inhaler
  • Placebo
  • (no location specified)
Feb 7, 2022

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

Asthma Trial (mometasone furoate dry powder inhaler, Budesonide DPI)

Completed
Has Results
  • Asthma
  • mometasone furoate dry powder inhaler
  • Budesonide DPI
  • (no location specified)
Feb 7, 2022

Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),

Completed
  • Healthy Volunteer
  • Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
  • Vardenafil Oral Tablet
  • Prahran, Victoria, Australia
    Nucleus Network, Burnet Institute
Nov 2, 2022

Asthma Trial in Enschede, Nijverdal, Rotterdam (ELLIPTA, BREEZHALER)

Completed
  • Asthma
  • ELLIPTA
  • BREEZHALER
  • Enschede, Netherlands
  • +2 more
Oct 7, 2021

COVID-19 Trial (Delcetravir dry powder inhaler)

Not yet recruiting
  • COVID-19
  • Delcetravir dry powder inhaler
  • (no location specified)
Jul 10, 2022

COPD Trial in Manchester (CHF 1535 NEXThaler 800/48, CHF 1535 NEXThaler 200/12, CHF 1535 NEXThaler PLACEBO)

Completed
  • COPD
  • CHF 1535 NEXThaler 800/48
  • +4 more
  • Manchester, United Kingdom
    Medicine Evaluation Unit
Oct 28, 2021

Refractory Chronic Cough Trial in Phoenix, Leesburg, Winter Park (3 mg NOC-100 (via nebulizer), 1 mg NOC-110 (via DPI) [1x 1 mg

Completed
  • Refractory Chronic Cough
  • 3 mg NOC-100 (via nebulizer)
  • +5 more
  • Phoenix, Arizona
  • +2 more
Nov 16, 2022

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Aug 15, 2022

Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)

Completed
Has Results
  • Asthma
  • Mometasone furoate/formoterol (MF/F) MDI
  • Fluticasone propionate/salmeterol (F/SC) DPI
  • (no location specified)
Feb 7, 2022

Pulmonary Arterial Hypertension Trial in Darlinghurst, Hobart, Melbourne (Drug: RT234 - vardenafil inhalation powder; Device:

Completed
  • Pulmonary Arterial Hypertension
  • Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Apr 20, 2022

Asthma Trial in Denver (Qvar, Flovent Diskus)

Terminated
  • Asthma
  • Denver, Colorado
    National Jewish Medical and Research Center
Nov 19, 2021

Asthma Trial in Huntington Beach, Raleigh, San Antonio (Fluticasone Propionate MDPI, Fluticasone Propionate/Salmeterol MDPI,

Completed
  • Asthma
  • Fluticasone Propionate MDPI
  • +2 more
  • Huntington Beach, California
  • +2 more
Nov 5, 2021

Asthma Trial in Raleigh, Edmond, San Antonio (Treatment A: Fp MDPI, Treatment B: FS MDPI, Treatment C Flovent)

Completed
  • Asthma
  • Treatment A: Fp MDPI
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 6, 2021

COPD Trial in Sofia (CHF 5993 DPI, CHF5993 pMDI, CHF 1535 pMDI)

Completed
  • Chronic Obstructive Pulmonary Disease
  • CHF 5993 DPI
  • +4 more
  • Sofia, Bulgaria
    Medical Center Convex EOOD
Apr 8, 2021

COPD Trial in Parma (Inhalation through Chiesi NEXThaler DPI)

Completed
  • COPD
  • Inhalation through Chiesi NEXThaler DPI
  • Parma, Italy
    Ospedale di Parma
Oct 28, 2021

COPD, COPD Exacerbation Trial in Winston-Salem (Nebulizers, Dry Powder Inhaler, Brovana)

Terminated
Has Results
  • COPD
  • COPD Exacerbation
  • Nebulizers
  • +6 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health
Jun 10, 2021

Asthma Trial in Berlin (AZD8154 nebuliser, AZD8154 Monodose DPI presented in capsules, AZD8154 Placebo Monodose DPI presented in

Terminated
  • Asthma
  • AZD8154 nebuliser
  • +2 more
  • Berlin, Germany
    Research Site
Aug 23, 2021

Asthmatic Trial in Manchester (NEXThaler 100/6 mcg DPI, Flixotide Accuhaler 500 mcg, NEXThaler 200/6 mcg DPI)

Completed
  • Asthmatic
  • NEXThaler 100/6 mcg DPI
  • +3 more
  • Manchester, United Kingdom
    The Medicine Evaluation Unit
Oct 28, 2021